EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic testing for inherited arrhythmia syndromes and cardiomyopathies: results of the European Heart Rhythm Association survey

Ivan Zeljkovic iD, Anaïs Gauthey iD, Martin Manninger iD, Katarzyna Malaczynska-Rajpold iD, Jacob Tfelt-Hansen iD, Lia Crotti iD, Elijah R Behr iD, Federico Migliore iD, Arthur Wilde iD, Julian Chun iD, Giulio Conte iD

Europace · 2024

DOI: 10.1093/europace/euae216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Ivan Zeljkovic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Dubrava University Hospital, Zagreb, Croatia. Hauptthemen laut MEDLINE: Genetic Testing, Arrhythmias, Cardiac, Cardiomyopathies, Health Care Surveys. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Indications and clinical impact of genetic testing for cardiac diseases have increased significantly over the past years. The aim of this physician-based European Heart Rhythm Association (EHRA) survey was to assess current clinical practice and access to genetic testing for cardiac diseases across European Society of Cardiology countries and to evaluate adherence to the 2022 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on genetic testing. Methods and results An online questionnaire composed of 28 questions was submitted to the EHRA Research Network and European Reference Network GUARD-Heart healthcare partners and promoted via dedicated social media channels. There were 357 respondents from 69 countries, 40% working in a hospital setting with a cardiac genetic service and/or a dedicated clinic focusing on inherited cardiac diseases and 27% with an onsite genetic laboratory. No genetic testing or low annual rate (<10/year) was declared by 39% of respondents. The majority of respondents (78%) declared issues or limitations to genetic testing access in their clinical practice. The main reasons for not providing or limited access to genetic testing were no availability of dedicated unit or genetic laboratory (35%) or reimbursement issues (25%). The most frequently reported indication for genetic testing was diagnostic purpose (55%). Most respondents (92%) declared offering genetic testing preceded by genetic counselling and 42% regular multidisciplinary evaluations for patients with cardiac genetic diseases. The perceived value of genetic testing in the diagnostic, prognostic, and therapeutic assessment was variable (67, 39, and 29%, respectively) and primarily based on the specific inherited disease. The majority of respondents recommended cascade genetic testing for the first-degree family members in case of pathogenic/likely pathogenic variant in the proband.

Conclusion

This survey highlights a significant heterogeneity of genetic testing access and provision and issues attributable to the availability of dedicated unit/genetic laboratory and reimbursement. However, adequate adherence to indications in the current recommendations for genetic testing in patients with cardiac diseases was observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingArrhythmias, CardiacCardiomyopathiesHealth Care SurveysGenetic Predisposition to DiseaseHumansEuropePractice Patterns, Physicians'Health Services AccessibilityGuideline AdherencePredictive Value of TestsSurveys and Questionnaires

Stichwörter der Autor:innen

CardiomyopathiesEHRA surveyGenetic heart diseaseGenetic testingInherited arrhythmogenic diseasesInherited primary arrhythmia syndromesSudden cardiac death

Autor:innen und Institutionen

  • Cardiology Department, Dubrava University Hospital, Zagreb, Croatia.
  • Heart Rhythm Management Center, Universitair Ziekenhuis Brussel-Vrije Universiteit, Brussels, Belgium.
  • Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Cardiology Department, Royal Brompton Hospital, Guy's and St Thomas NHS Foundation Trust, London, UK.
  • Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Ivan Zeljkovic, Anaïs Gauthey, Martin Manninger, Katarzyna Malaczynska-Rajpold, Jacob Tfelt-Hansen, Lia Crotti, Elijah R Behr, Federico Migliore, Arthur Wilde, Julian Chun, Giulio Conte

Zitieren

APA

Zeljkovic, I., Gauthey, A., Manninger, M., Malaczynska-Rajpold, K., Tfelt-Hansen, J., Crotti, L., Behr, E. R., Migliore, F., Wilde, A., Chun, J., & Conte, G. (2024). Genetic testing for inherited arrhythmia syndromes and cardiomyopathies: results of the European Heart Rhythm Association survey. Europace. https://doi.org/10.1093/europace/euae216

Vancouver

Zeljkovic I, Gauthey A, Manninger M, Malaczynska-Rajpold K, Tfelt-Hansen J, Crotti L, et al. Genetic testing for inherited arrhythmia syndromes and cardiomyopathies: results of the European Heart Rhythm Association survey. Europace. 2024. doi:10.1093/europace/euae216

BibTeX
@article{Zeljkovic2024,
  author = {Zeljkovic, Ivan and Gauthey, Anaïs and Manninger, Martin and Malaczynska-Rajpold, Katarzyna and Tfelt-Hansen, Jacob and Crotti, Lia and Behr, Elijah R and Migliore, Federico and Wilde, Arthur and Chun, Julian and Conte, Giulio},
  title = {Genetic testing for inherited arrhythmia syndromes and cardiomyopathies: results of the European Heart Rhythm Association survey},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae216}
}
Kostenlos starten →